Liver cancer early diagnosis risk prediction model construction method
By constructing a big data-based risk prediction model for early diagnosis of liver cancer, the problems of insufficient accuracy of liver cancer prediction models and lack of clinical diagnosis and treatment evaluation system in existing technologies have been solved, achieving the effect of improving early diagnosis rate and predicting treatment effects.
Patent Information
- Application Number
- CN202510554760.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-29
- Publication Date
- 2025-09-16
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing liver cancer prediction model uses risk scoring to make predictions, which is inaccurate and unreliable, and lacks a clinical diagnosis and treatment evaluation system, resulting in a low early diagnosis rate and an inability to predict clinical treatment effects and postoperative recurrence risks in advance.
Construct a risk prediction model for early diagnosis of liver cancer. By processing, analyzing and learning clinical data, establish a project database of clinical diagnostic pathways for hepatocellular carcinoma based on big data, determine the main diagnostic points in the temporal diagnostic scheme of the disease and related indicators affecting postoperative outcomes, formulate rules for extracting diagnostic and treatment pathways, build a quality and efficiency evaluation indicator system, calculate the probability of early diagnosis and postoperative recurrence, and establish a Markov model for risk prediction.
It improves the accuracy and reliability of early diagnosis of liver cancer, enhances the scientific nature of clinical diagnosis and treatment decisions, can predict treatment effects and postoperative recurrence risks in advance, and improves the early diagnosis rate and treatment effect of HCC.